Idrastil

Sodium Hyaluronate, the active ingredient in Idrastil, is a viscoelastic compound presented as eye drops for ocular use. It helps to lubricate the eye surface and stabilize the tear film, supporting patients with dry eye and postoperative ocular discomfort. It is formulated to provide long‑lasting hydration and is indicated for use in patients requiring ocular surface protection.

GNH USA supplies Idrastil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Idrastil (sodium hyaluronate) is used to address ocular surface lubrication disorders, primarily dry eye disease and related conditions.

Dry eye syndrome: improves tear film stability and reduces ocular surface irritation. Post‑surgical eye care: enhances ocular surface healing and provides lubrication after cataract or refractive surgery. Contact lens discomfort: reduces friction and dryness for lens wearers. Keratoconjunctivitis sicca: alleviates symptoms by maintaining moisture on the cornea.

Idrastil may cause ocular adverse reactions, most of which are mild and transient.

Common Side Effects: - Transient blurred vision - Mild eye irritation or burning - Temporary increased tearing

Serious or Rare Side Effects: - Allergic reaction with swelling or rash - Severe eye pain or photophobia - Corneal ulceration

Before using Idrastil, consider the following precautions to ensure safe and effective treatment.

Allergy assessment: verify no known hypersensitivity to sodium hyaluronate or formulation excipients. Contact lens wearers: remove lenses before instillation and wait at least 5 minutes before reinserting. Concurrent ocular medications: space administration of other eye drops by at least 5 minutes. Pregnancy and lactation: safety not established; use only if clearly needed after risk‑benefit evaluation. Active eye infection: avoid use until infection is resolved. Store at room temperature: keep in original container, protect from light and moisture.

Idrastil can interact with other ophthalmic products; consider the following interactions.

Major Interactions (Avoid): - Use with ophthalmic anesthetic agents: may increase corneal toxicity. - Combination with preservative‑containing drops: risk of additive ocular irritation.

Moderate Interactions (Monitor Closely): - Antihistamine eye drops: may reduce lubrication effectiveness. - Topical corticosteroids: monitor for delayed wound healing. - Systemic antihistamines: may exacerbate dry eye symptoms.